Intech Investment Management LLC Purchases 1,808 Shares of Option Care Health, Inc. $OPCH

Intech Investment Management LLC raised its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 1.5% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 122,000 shares of the company’s stock after purchasing an additional 1,808 shares during the quarter. Intech Investment Management LLC owned 0.08% of Option Care Health worth $3,963,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in OPCH. Envestnet Asset Management Inc. raised its holdings in Option Care Health by 14.9% in the 1st quarter. Envestnet Asset Management Inc. now owns 184,180 shares of the company’s stock worth $6,437,000 after acquiring an additional 23,849 shares during the last quarter. Cerity Partners LLC bought a new position in shares of Option Care Health during the first quarter valued at $303,000. CWM LLC boosted its position in shares of Option Care Health by 245.1% during the first quarter. CWM LLC now owns 3,375 shares of the company’s stock valued at $118,000 after buying an additional 2,397 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Option Care Health in the 1st quarter worth about $6,636,000. Finally, Avantax Advisory Services Inc. purchased a new position in Option Care Health in the 1st quarter worth about $494,000. Institutional investors own 98.05% of the company’s stock.

Insider Activity at Option Care Health

In other news, Director Norman L. Wright bought 3,411 shares of Option Care Health stock in a transaction that occurred on Tuesday, September 9th. The stock was bought at an average cost of $29.31 per share, with a total value of $99,976.41. Following the acquisition, the director owned 15,501 shares of the company’s stock, valued at $454,334.31. The trade was a 28.21% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy P. Sullivan purchased 20,000 shares of the stock in a transaction on Thursday, August 21st. The shares were purchased at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the acquisition, the director directly owned 49,229 shares of the company’s stock, valued at approximately $1,354,289.79. This represents a 68.43% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders purchased 61,411 shares of company stock worth $1,637,416. 0.64% of the stock is owned by company insiders.

Option Care Health Price Performance

NASDAQ OPCH opened at $28.28 on Wednesday. The business’s fifty day moving average is $27.72 and its 200 day moving average is $29.51. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The company has a market capitalization of $4.49 billion, a PE ratio of 22.62, a price-to-earnings-growth ratio of 1.74 and a beta of 0.88.

Analyst Upgrades and Downgrades

OPCH has been the subject of a number of research analyst reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Option Care Health in a research note on Thursday, November 13th. Cowen initiated coverage on shares of Option Care Health in a research note on Thursday, October 2nd. They set a “hold” rating for the company. Wall Street Zen cut Option Care Health from a “buy” rating to a “hold” rating in a report on Saturday. Citizens Jmp cut their price objective on Option Care Health from $38.00 to $36.00 and set a “market outperform” rating for the company in a report on Friday, October 31st. Finally, Morgan Stanley initiated coverage on Option Care Health in a report on Friday, October 17th. They issued an “overweight” rating and a $35.00 target price on the stock. Nine equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $35.67.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.